The broken balance in aspirin hypersensitivity

European Journal of Pharmacology

Volumn 533, Issue 1-3, 2006, Pages 145-155

  Szczeklik, Andrzej ^a   Sanak, Marek ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Aspirin hypersensitivity; Cyclooxygenase; Cysteinyl leukotriene; Lipoxin; Non steroid anti inflammatory drug

Indexed keywords

ACETYLSALICYLIC ACID; AE 248; ANSAD; CELECOXIB; CILNORIL; CORTICOSTEROID; DICLOFENAC; DICLOFENAC POTASSIUM; DIFLUNISAL; DIPYRONE; DOLBID; ETODOLAC; FENOPROFEN; FENOPROFEN CALCIUM; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; KETOPROFEN; KETOROLAC; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE INHIBITOR; MECLOFENAMATE SODIUM; MEFENAMIC ACID; MELOXICAM; MORTIN; NABUMETONE; NAPROXEN; NIMESULIDE; ORUVAL; OXAPROZIN; PARACETAMOL; PIROXICAM; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; PYRALGINUM; ROFECOXIB; SALSALATE; STEROID; SULINDAC; TOLMETIN; UNCLASSIFIED DRUG;

ANGIONEUROTIC EDEMA; ASTHMA; BRONCHOSPASM; CLINICAL FEATURE; CLINICAL TRIAL; DRUG CROSS REACTIVITY; DRUG MEGADOSE; ENZYME INHIBITION; HUMAN; HYPERSENSITIVITY REACTION; ICOSANOID METABOLISM; MAST CELL; META ANALYSIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RHINOSINUSITIS; SYSTEMATIC REVIEW; URTICARIA;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; ASTHMA; CYCLOOXYGENASE INHIBITORS; DRUG HYPERSENSITIVITY; HUMANS; LEUKOTRIENES; LIPOXINS; LIPOXYGENASE INHIBITORS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; URTICARIA;

EID: 33644761816     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.12.053     Document Type: Review

References (119)

1. A. Alonso-Llamazares, C. Martinez-Cocera, J. Dominguez-Ortega, T. Robledo-Echarren, M. Cimarra-Alvarez, and M. Mesa del Castillo Nasal provocation test (NPT) with aspirin: a sensitive and sale method to diagnose aspirin-induced asthma (aspirin-induced asthma) Allergy 57 2002 632 635
2. A. Antczak, P. Montuschi, S. Kharitonow, P. Górski, and P.J. Barnes Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma Am. J. Respir. Crit. Med. 166 2002 301 306
3. J. Arm, and K.F. Austen Leukotriene receptors and aspirin sensitivity N. Engl. J. Med. 347 2002 1524 1526
4. 4 on the airway responsiveness to histamine in subjects with asthma and normal subjects J. Allergy Clin. Immunol. 82 1988 654 660
5. 4 synthase gene polymorphism and clinical response to a cys-LTs antagonist, pranlukast Pharmacogenetics 12 2002 565 570
6. R. Asero, A. Tedeshi, and M. Lorini Autoreactivity is highly prevalent in patients with multiple intolerances to NSAIDs Ann. Allergy Asthma Immunol. 88 2002 468 472
7. N.G. Bazan, and R.J. Flower Lipid signals in pain control Nature 420 2002 136 138
8. M.P. Berges-Gimeno, R.A. Simon, and D.D. Stevenson The effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactions Clin. Exp. Allergy 32 2002 1491 1496
9. M.P. Berges-Gimeno, R.A. Simon, and D.D. Stevenson The natural history and clinical characteristics of aspirin exacerbated respiratory disease Ann. Allergy Asthma Immunol. 89 2002 472 478
10. G. Bochenek, E. Nizankowska, and A. Szczeklik Testing for aspirin hypersensitivity Allergy 57 2002 562 565
11. K. Brune, and B. Hinz The discovery and development of antiinflammatory drugs Arthritis Rheum. 50 2004 2391 2399
12. J. Casadevall, P.J. Ventura, J. Mullol, and C. Picado Intranasal challenge with aspirin in the diagnosis of aspirin intolerant asthma: evaluation of nasal response by acoustic rhinometry Thorax 55 2000 921 924
13. N.V. Chandrasekharan, H. Dai, K.L.T. Roos, N.K. Evanson, J. Tomsik, T.S. Elton, and D.L. Simmons COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression Proc. Natl. Acad. Sci. U. S. A. 99 2002 13926 13931
14. C. Chavis, J. Vachier, P. Godard, J. Bousquet, and P. Chanez Lipoxins and other arachidonate-derived mediators in bronchial asthma Thorax 55 2000 S38 S41
15. J.H. Choi, K.W. Lee, H.B. Oh, K.J. Lee, Y.J. Suh, C.S. Park, and H.S. Park HLA association in aspirin-intolerant asthma: DPB1 0301 as a strong marker in a Korean population J. Allergy Clin. Immunol. 113 2004 562 564
16. R.A. Cooke Allergy in drug idiosyncrasy JAMA 73 1919 759
17. C. Corrigan, K. Mallett, S. Ying, D. Roberts, A. Parikh, G. Scadding, and T. Lee Expression of the cysteinyl leukotriene receptors cysLT(1) and cysLT(2) in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis J. Allergy Clin. Immunol. 115 2005 316 322
18. 4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma J. Clin. Invest. 101 1998 834 846
19. 4 excretion during aspirin challenges with severity of respiratory responses J. Allergy Clin. Immunol. 103 1999 559 564
20. B. Dahlen, E. Niżankowska, A. Szczeklik, O. Zetterstrom, G. Bochenek, M. Kumlin, L. Mastalerz, G. Pinis, L.J. Swanson, T.I. Boodhoo, S. Wright, L.M. Dube, and S.E. Dahlen Benefits from adding the 5-lipooxygenase inhibitor Zileuton to conventional therapy in aspirin-intolerant asthmatics Am. J. Respir. Crit. Care Med. 157 1998 1187 1194
21. B. Dahlen, A. Szczeklik, and J.J. Murray Celecoxib in patients with asthma and aspirin intolerance N. Engl. J. Med. 344 2001 142
22. S.E. Dahlen, K. Malmstrom, E. Niżankowska, B. Dahlen, P. Kuna, M. Kowalski, W.R. Lumry, C. Picado, D.D. Stevenson, J. Bousquet, R. Pauwels, S.T. Holgate, A. Shahane, J. Zhang, T.F. Reiss, and A. Szczeklik Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist. A randomized, double-blind, placebo-controlled trial Am. J. Respir. Crit. Care Med. 165 2002 9 14
23. J.W. Dekker, E. Niżankowska, M. Schmitz-Schumann, K. Pile, G. Bochenek, A. Dyczek, W.O. Cookson, and A. Szczeklik Aspirin-induced asthma and HLA-DRB1 and HLA-DPB1 genotypes Clin. Exp. Allergy 27 1997 574 577
24. E. Enrique, P. Garcia-Ortega, P. Gaig, and M.M. San Miguel Failure of montelukast to prevent anaphylaxis to diclofenac Allergy 54 1999 529 530
25. K. Fukunaga, P. Kohli, C. Bonnans, L.E. Fredenburgh, and B.D. Levy Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury J. Immunol. 174 2005 5033 5039
26. P. Gamboa, M.L. Sanz, M.R. Caballero, I. Urrutia, I. Antepara, R. Esparza, and A.L. de Weck The flow-cytometric determination of basophil activation induced by aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome Clin. Exp. Allergy 34 2004 1448 1457
27. D.A. Groneberg, W. Heppt, P. Welker, C. Peiser, Q.T. Dinh, A. Cryer, M. Zweng, C. Witt, and A. Fischer Aspirin-sensitive rhinitis-associated changes in upper airway innervation Eur. Respir. J. 22 2003 986 991
28. R.J. Gryglewski, A. Szczeklik, E. Olszewski, A. Dembińska- Kieć, and G. Czerniawska-Mysik Aspirin-sensitive asthma: the effect of aspirin on prostaglandin release from slices of nasal polyps Pharmacol. Res. Commun. 9 1977 415 425
29. I. Grzelewska-Rzymowska, M. Szmidt, and J. Rożniecki Aspirin-sensitive urticaria; clinical study Pneumonol. Alergol. Pol. 61 1993 24 28
30. P. Gyllfors, G. Bochenek, J. Overholt, D. Drupka, M. Kumlin, J. Sheller, E. Niżankowska, P.C. Isakson, F. Mejza, J.B. Lefkowith, S.E. Dahlen, and A. Szczeklik Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib J. Allergy ClinImmunol. 111 2003 1116 1121
31. 2 in airways of subjects with asthma Am. J. Respir. Crit. Care Med. 162 2000 637 640
32. J. Hedman, J. Kaprio, T. Poussa, and M.M. Neminen Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study Int. J. Epidemiol. 28 1999 717 722
33. B.M. Henz The spectrum of urticaria B.M. Henz T. Zuberbier J. Grabbe E. Monroe Urticaria - Clinical, Diagnostic and Therapeutic Aspects 1998 Springer Berlin 1 17
34. V.G.S. Hirschberg Mittelung uber einen Fall von Nebenwirkung des Aspirin. A case report on the side effects of aspirin. Dtsch. Med. Wochenschr., 28, 416 and 1990 Allergy Proc. 11 1902 249 250
35. S.T. Holgate, M. Peters-Golden, R.A. Panettieri, and W.R. Henderson Jr. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling J. Allergy Clin. Immunol. 111 2003 S18 S36
36. K. Inoue, H. Takano, Y. Kawahito, H. Sano, and T. Yosikawa Cyclooxygenase-2 inhibitors in aspirin-induced asthma Chest 123 2003 1317 1318
37. C. Jenkins, J. Costello, and L. Hodge Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice BMJ 328 2004 434
38. L. Kasper, K. Sładek, M. Duplaga, G. Bochenek, J. Liebhart, U. Gładysz, J. Małolepszy, and A. Szczeklik Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland Allergy 58 2003 1064 1066
39. 4 synthase promoter polymorphism in Japanese patients with aspirin-induced asthma J. Allergy Clin. Immunol. 109 2002 936 942
40. S.A. Kharitonov, and P.J. Barnes Exhaled markers of pulmonary disease Am. J. Respir. Crit. Care Med. 163 2001 1693 1722
41. M.L. Kowalski, R. Pawliczak, J. Woźniak, M. Siuda, J. Poniatowska, T. Iwaszkiewicz, T. Kornatowski, and M.A. Kaliner Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients Am. J. Respir. Crit. Care Med. 161 2000 391 398
42. M.L. Kowalski, J. Grzegorczyk, R. Pawliczak, T. Kornatowski, M. Wagrowska-Danilewicz, and M. Danilewicz Decreased apoptosis and distinct profile of infiltrating cells in the nasal polyps of patients with aspirin hypersensitivity Allergy 57 2002 493 500
43. M.L. Kowalski, A. Ptasińska, A. Bienkiewicz, R. Pawliczak, and L. DuBuske Differential effects of aspirin and misoprostol on 15- hydroxyeicosatetraenoic acid generation by leukocytes from aspirin-sensitive asthmatic patients J. Allergy Clin. Immunol. 112 2003 505 512
44. T. Kunikata, H. Yamane, E. Sego, T. Matsuoka, Y. Sugimoto, S. Tanaka, H. Tanaka, H. Nagai, A. Ichikawa, and S. Narumiya Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3 Nature Immunol. 6 2005 524 531
45. N. Lazzeri, M.G. Belvisi, H.J. Patel, M.H Yacoub, K.F. Chung, and J.A. Mitchell Effects of prostaglandin E2 and CAMP elevating drugs on GM-CSF release by cultured human airway smooth muscle cells. Relevance to asthma therapy Am. J. Respir. Cell. Mol. Biol. 24 2001 44 48
46. B.D. Levy, G.T. De Sanctis, P.R. Devhand, E. Kim, K. Ackerman, B.A Schmidt, W. Szczeklik, J.M. Drazen, and C.N. Serhan Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4 Nature Med. 8 2002 1018 1023
47. L.R. Lynch, G.P. O'Neill, Q. Liu, D.-S. Im, N. Sawyer, K.M. Metters, N. Coulombe, M. Abramovitz, Z. Zeng, B.M. Connoly, C. Bai, C.P. Austin, A. Chateauneuf, R. Stocco, G.M. Greig, S. Kargman, S.B. Hooks, D.L. Williams Jr., A.W. Ford-Hutchinson, C.T. Caskey, and J.F. Evans Characterization of the human cysteinyl leukotriene CysLT1 receptor Nature 399 1999 789 793
48. X.D. Martin, and B. Duvoisin Ocular complications of the Fernand-Widal triad and its therapy Ophthalmologica 217 2003 160 163
49. L. Mastalerz, M. Milewski, M. Duplaga, E. Niżkowska, and A. Szczeklik Intranasal fluticasone propionate for chronic eosinophilic rhinitis in patients with aspirin-induced asthma Allergy 52 1997 895 900
50. L. Mastalerz, A. Gawlewicz-Mroczka, E. Niżankowska, A. Ćmiel, and A. Szczeklik Protection against exercise-induced bronchoconstriction by montelukast in aspirin-sensitive and aspirin-tolerant patients with asthma Clin. Exp. Allergy 32 2002 1360 1365
51. L. Mastalerz, E. Niżankowska, M. Sanak, F. Mejza, M. Pierzchalska, S. Bazan-Socha, A. Bestyñska-Krypel, A. Ćmiel, and A. Szczeklik Clinical and genetic features underlying the response of patients with bronchial asthma to treatment with a leukotriene receptor antagonist Eur. J. Clin. Invest. 32 2002 1360 1365
52. L. Mastalerz, M. Setkowicz, M. Sanak, and A. Szczeklik Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma J. Allergy Clin. Immunol. 113 2004 771 775
53. Mastalerz, L., Setkowicz, M., Sanak, M., Rybarczyk, Szczeklik, A., in press. Familial aggregation of aspirin-induced urticaria and leukotriene C4 synthase allelic variant. British Journal of Dermatology. doi:10.1111/j.1365- 2133.2005.06851.x (online publication date: 25 Aug. 2005).
54. L. Mattucci, O. Rossi, L. Cecchi, A. Vultaggio, P. Parronchi, F. Brugnolo, E. Maggi, and S. Romagnani Coronary vasospasm during an acute allergic reaction Allergy 57 2002 865 866
55. G. Melillo, G. Balzano, S. Bianco, B. Dahlen, P. Godard, M.L. Kowalski, C. Picado, D.D. Stevenson, and S. Suetsugu Report of the INTERASMA Working Group on standardization of inhalation provocation tests in aspirin-induced asthma Allergy 56 2001 899 911
56. E.A. Mellor, N. Frank, D. Soler, M.R. Hodge, J.M. Lora, K.F. Austen, and J.A. Boyce Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: functional distinction from CysLT1R Proc. Natl. Acad. Sci. U. S. A. 100 2003 11589 11593
57. M. Milewski, L. Mastalerz, E. Niżankowska, and A. Szczeklik Nasal provocation test for diagnosis of aspirin-induced asthma J. Allergy Clin. Immunol. 101 1998 581 586
58. M. Moore-Robinson, and R.P. Warin Effect of salicylates in urticaria Br. Med. J. 4 1967 262 264
59. J. Mullol, J.C. Fernandez-Morata, J. Roca-Ferrer, L. Pujols, A. Xaubet, P. Benitez, and C. Picado Cyclooxygenase 1 and cyclooxygenase 2 expression in abnormally regulated in human nasal polyps J. Allergy Clin. Immunol. 109 2002 824 830
60. S.M. Nasser, and T.H. Lee Leukotrienes in aspirin-sensitive asthma A. Szczeklik R.J. Gryglewski J. Vane Eicosanoids, Aspirin and Asthma 1998 Marcel Dekker New York 317 336
61. M.S. Nasser, and T.H. Lee Products of 15-lipoxygenase: are they important in asthma? Clin. Exp. Allergy 32 2002 1540 1542
62. E. Nettis, P.R. Di, A. Ferrannini, and A. Tursi Tolerability of Rofecoxib in patients with cutaneous adverse reactions to nonsteroidial anti-inflammatory drugs Ann. Allergy Asthma Immunol. 88 2002 331 334
63. E. Niżankowska, A. Bestyńska-Krypel, A. Ćmiel, and A. Szczeklik Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma Eur. Respir. J. 15 2000 863 869
64. B. Novotna, H. Smerkova, and V. Vlckova Effect of aspirin on 15-hrydoxyeicosatetraenoic acid (15-HETE) generation by leukocytes from aspirin-sensitive patients Allergy Clin. Immunol. Intern. Suppl. 1 2005 375
65. E. Nucera, D. Schiavino, A. Milani, M. DelNinno, C. Misurca, A. Buonomo, C. D'Ambrosio, G. Paludetti, and G. Patriarca Effects of lysine-acetylsalicylate (LAS) treatment in nasal polyposis: Two controlled long term prospective follow up studies Thorax 55 2000 575 578
66. Y. Obase, T. Shimoda, S. Tomari, K. Mitsuta, T. Kawano, H. Matsuse, and S. Kohno Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients Chest 121 2002 143 150
67. I.D. Pavord, and A.E. Tattersfield Bronchoprotective role for endogenous prostaglandin E2 Lancet 345 1995 436 438
68. C.A. Perez-Novo, M.L. Kowalski, P. Kuna, A. Ptasinska, G. Holtappels, P. van Cauwenberge, P. Gevaert, S. Johannson, and C. Bachert Aspirin sensitivity and IgE antibodies to Staphylococcus aureus enterotoxins in nasal polyposis: studies on the relationship Int. Arch. Allergy Immunol. 133 2004 255 260
69. C. Picado Aspirin intolerance and nasal polyposis Curr. Allergy Asthma Rep. 2 2002 488 493
70. C. Picado, J.C. Fernandez-Morata, M. Juan, J. Roca-Ferrer, M. Fuentes, A. Xaubet, and J. Mullol Cyclooxygenase-2 mRNA is down-expressed in nasal polyps from aspirin-sensitive asthmatics Am. J. Respir. Cell. Mol. Biol. 160 2000 291 296
71. L. Pujols, J. Mullol, I. Alobid, J. Roca-Ferrer, A. Xaubet, and C. Picado Dynamics of COX-2 in nasal mucosa and nasal polyps from aspirin-tolerant and aspirin-intolerant patients with asthma J. Allergy Clin. Immunol. 114 2004 814 819
72. A. Rosado, R. Vives, R. Gonzalez, and J. Rodriguez Can NSAIDs intolerance disappear? A study of three cases Allergy 58 2003 689 690
73. A.P. Sampson Drug-induced asthma: NSAID beta-blockers and ACE inhibitors S.I. Holgate H.A. Boushey L.M. Fabbri Difficult Asthma 1999 Martin Dunitz London 127 138
74. 4 synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast Thorax 55 2000 S28 S31
75. S. Samter, and R.F. Beers Jr. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis Ann. Intern. Med. 68 1968 975 983
76. M. Sanak, and A.P. Sampson Biosynthesis of cysteinyl-leucotrienes in aspirin intolerant asthma Clin. Exp. Allergy 29 1999 306 313
77. M. Sanak, and A. Szczeklik Leukotriene C4 synthase polymorphism and aspirin-induced asthma J. Allergy Clin. Immunol. 107 2001 561
78. M. Sanak, H.-U. Simon, and A. Szczeklik Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma Lancet 350 1997 1599 1600
79. M. Sanak, B.D. Levy, C.B. Clish, N. Chiang, K. Gronert, L. Mastalerz, C.N. Serhan, and A. Szczeklik Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics Eur. Respir. J. 16 2000 44 49
80. M. Sanak, M. Pierzchalska, S. Bazan-Socha, and A. Szczeklik Enhanced expression of the leukotriene C4 synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma Am. J. Respir. Cell. Mol. Biol. 23 2000 290 296
81. M. Sanak, B. Kiełbasa, G. Bochenek, and A. Szczeklik Exhaled eicosanoids following oral aspirin challenge in asthmatic patients Clin. Exp. Allergy 34 2004 1899 1904
82. G.K. Scadding Comparison of medical and surgical treatment of nasal polyposis Curr. Allergy Asthma Rep. 2 2002 494 499
83. D. Schäfer, M. Schmid, U.C. Gode, and H.W. Baenkler Dynamics of eicosanoids in peripheral blood cells during bronchial provocation in aspirin-intolerant asthmatics Eur. Respir. J. 13 1999 638 646
84. M. Schmitz-Schumann, G. Menz, C. Kohl, and C. Virchow Adaptive desaktivierung bei analgetika-asthma syndrom: methodik und phanomene der toleranzinduktion Prax. Klin. Pneumol. 39 1985 868 869
85. K.J. Serio, C.R. Hodulik, and T.D. Bigby Sp1 and Sp3 function as key regulators of leukotriene C4 synthase gene expression in the monocyte-like cell line, THP-1 Am. J. Respir. Crit. Care Med. 23 2000 234 240
86. G.A. Settipane Landmark commentary: history of aspirin intolerance Allergy Proc. 11 1990 251 252
87. D. Simmons, R.M Botting, P.M. Robertson, M.L. Madsen, and J.R. Vane Induction of an acetaminophen-sensitive cyclooxygenase with reduced sensitivity to nonsteroid antiinflammatory drugs Proc. Natl. Acad. Sci. U. S. A. 96 1999 3275 3280
88. A.R. Sousa, A. Parkih, G. Scadding, C.J. Corrigan, and T.H. Lee Leukotriene receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis N. Engl. J. Med. 347 2002 1493 1499
89. D.D. Stevenson, and R.A. Simon Sensitivity to aspirin and nonsteroidal anti inflammatory drugs E. Middleton C.E. Adkinson N.F. Yunginger J.W. Busse Allergy Principle and Practice 1998 Mosby St Louis 1225 1234
90. D.D. Stevenson, and R.A. Simon Lack of cross-reactivity between rofecoxib and aspirin-sensitive patients with asthma J. Allergy Clin. Immunol. 108 2001 47 51
91. D.D. Stevenson, R.A. Simon, and D.A. Mathison Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics Ann. Allergy Asthma Immunol. 85 2000 477 482
92. M. Świerczyńska, E. Niżankowska-Mogilnicka, J. Zarychta, A. Gielicz, and A. Szczeklik Nasal versus bronchial and nasal response to oral aspirin challenge: clinical and biochemical differences between patients with aspirin-induced asthma/rhinitis J. Allergy Clin. Immunol. 112 2003 995 1001
93. A. Szczeklik Aspirin-induced asthma as a viral disease Clin. Allergy 18 1988 15 20
94. A. Szczeklik The cyclooxygenase theory of aspirin-induced asthma Eur. Respir. J. 3 1990 588 593
95. A. Szczeklik Prostaglandin E2 and aspirin-induced asthma Lancet 345 1995 1056
96. A. Szczeklik, and M. Sanak The role of COX-1 and COX-2 in asthma pathogenesis and its significance in the use of selective inhibitors Clin. Exp. Allergy 32 2002 339 342
97. A. Szczeklik, and D.D. Stevenson Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management J. Allergy Clin. Immunol. 111 2003 913 921
98. A. Szczeklik, R.J. Gryglewski, and G. Czerniawska-Mysik Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients Br. Med. J. 1 1975 67 69
99. A. Szczeklik, R.J. Gryglewski, and G. Czerniawska-Mysik Clinical patterns of hypersensitivity to nonsteroidal antiinflammatory drugs and their pathogenesis J. Allergy Clin. Immunol. 60 1977 276 284
100. A. Szczeklik, E. Niżankowska, and A. Serafin Autoimmune phenomena in bronchial asthma with special reference to aspirin intolerance Am. J. Respir. Crit. Care Med. 152 1995 1753 1756
101. A. Szczeklik, K. Sładek, R. Dworski, E. Niżankowska, J. Soja, J. Sheller, and J. Oates Bronchial aspirin challenge causes specific eicosanoid response in aspirin sensitive asthmatics Am. J. Respir. Crit. Care Med. 154 1996 1608 1614
102. A. Szczeklik, E. Niżankowska, and M. Duplaga Natural history of aspirin-induced asthma Eur. Respir. J. 16 2000 432 436
103. A. Szczeklik, E. Niżankowska, G. Bochenek, K. Nagraba, F. Mejza, and M. Świerczyńska Safety of a specific COX-2 inhibitor in aspirin-induced asthma Clin. Exp. Allergy 31 2001 219 225
104. A. Szczeklik, E. Niżankowska, L. Mastalerz, and G. Bochenek Myocardial ischemia possibly mediated by cysteinyl leukotrienes J. Allergy Clin. Immunol. 109 2002 572 573
105. J. Takasaki, M. Kamohara, M. Matsumoto, T. Saito, T. Sugimoto, T. Ohishi, H. Ishii, T. Ota, Y. Kawai, Y. Masuho, T. Isogi, Y. Suzuki, S. Sugano, and K. Furuichi The molecular characterisation and tissue distribution of the human cysteinyl leukotriene CysLT(2) receptor Biochem. Biophys. Res. Commun. 274 2000 316 322
106. A.E. Tattersfield, A.J. Knox, J.R. Britton, and I.P. Hall Asthma Lancet 360 2002 1313 1322
107. H. Vally, M.L. Taylor, and P.J. Thompson The prevalence of aspirin-intolerant asthma (aspirin-induced asthma) in Australian asthmatic patients Thorax 57 2002 569 574
108. A. Van der Veer Jr. The asthma problem N.Y. J. Med. 113 1920 392
109. R. Van Sambeek, D.D. Stevenson, M. Baldasaro, B.K. Lam, J.L. Zhao, S. Yoshida, C. Yandora, J.M. Drazen, and J.F. Penrose 5′ Flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States J. Allergy Clin. Immunol. 106 2000 72 76
110. J.R. Vane, and R.M. Botting The history of aspirin J.R. Vane R.M. Botting Aspirin and Other Salicylates 1992 Chapman and Hall London 3 16
111. P.A. Wark, S.L. Johnston, F. Bucchieri, R. Powell, S. Puddicombe, V. Laza-Stanca, S.T. Holgate, and D.E. Davies Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus J. Exp. Med. 21 2005 937 947
112. G.J. Whelan, K. Blake, N. Kissoon, L.J. Duckworth, J. Wang, J.E. Sylvester, and J.J. Lima Effect of montelukast on time-course of exhaled nitric oxide in asthma: influence of LTC4 synthase A(- 444)C polymorphism Pediatr. Pulmonol. 36 2003 413 420
113. M.F. Widal, P. Abramin, and J. Lermoyez Anaphylaxis et idiosyncrasie Presse Med. 30 1922 189 192
114. K.M. Woessner, R.A. Simon, and D.D. Stevenson The safety of celecoxib in patients with aspirin-sensitive asthma Arthritis Rheum. 46 2002 2201 2206
115. S. Yoshida, Y. Ishizaki, K. Onuma, T. Shoji, H. Nakagawa, and H. Amayasu Selective cyclo-oxygenase 2 inhibitor in patients with aspirin-induced asthma J. Allergy Clin. Immunol. 106 2000 1201 1202
116. S. Yoshida, H. Sakamoto, Y. Ishizaki, K. Onuma, T. Shoji, H. Nakagawa, H. Hasegawa, M. Nakabayashi, and H. Amayasu Efficacy of leukotriene receptor antagonist in bronchial hyperresponsiveness and hypersensitivity to analgesic in aspirin-intolerant asthma Clin. Exp. Allergy 30 2000 64 70
117. A. Zembowicz, L. Mastalerz, M. Setkowicz, W. Radziszewski, and A. Szczeklik Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiophatic urticaria with sensitivity to non-steroidial anti-inflammatory drugs Arch. Dermatol. 139 2003 1577 1582
118. A. Zembowicz, L. Mastalerz, M. Setkowicz, W. Radziszewski, and A. Szczeklik Histological spectrum of cutaneous reactions to aspirin in chronic idiopathic urticaria J.Cutan.Pathol. 31 2004 323 329
119. J.L. Zhao, F.K. Austen, and B.K. Lam Cell-specific transcription of leukotriene C4 synthase involves a Kruppel-like transcription factor and Sp1 J. Biol. Chem. 275 2000 8903 8910